| Companies sponsors |
Roche (obinutuzumab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Action on Pain |
| |
Arthritis Action |
| |
Arthritis & Musculoskeletal Alliance |
| |
Changing Faces |
| |
Genetic Alliance UK |
| |
Gene People |
| |
Hibbs Lupus Trust |
| |
Kidney Care UK |
| |
Let's Face it |
| |
Lupus Trust |
| |
Lupus UK |
| |
National Kidney Federation |
| |
National Rheumatoid Arthritis Society |
| |
Pain Concern |
| |
Pain UK |
| |
Polycystic Kidney Disease Charity |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
Thrombosis UK |
| Professional groups |
Association of Renal Industries |
| |
Association of Renal Technologists |
| |
British Association of Urological Nurses |
| |
British Association of Urological Surgeons |
| |
British Geriatrics Society |
| |
British Isles Lupus Assessment Group |
| |
British Society for Allergy and Clinical Immunology |
| |
British Society for Haematology |
| |
British Society for Rheumatology |
| |
British Society of Haemostasis and Thrombosis |
| |
Clinical Leaders of Thrombosis |
| |
Primary Care Rheumatology Society |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society for DGH Nephrologists |
| |
Society for Vascular Technology |
| |
Society for Vascular Ultrasound |
| |
Society of Vascular Nurses |
| |
UK Clinical Pharmacy Association |
| |
UK Kidney Association |
| |
UK Renal Pharmacy Group |
| |
Vascular Society of Great Britain and Ireland |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
Aspen (azathioprine) |
| |
Astellas Pharma (tacrolimus) |
| |
Baxter Healthcare (cyclophosphamide) |
| |
Chiesi (tacrolimus) |
| |
Celltrion Healthcare (rituximab) |
| |
Dexcel Pharm (ciclosporin) |
| |
GlaxoSmithKline (belimumab) |
| |
Leo Laboratories (tacrolimus) |
| |
Mylan (azathioprine, ciclosporin) |
| |
Nova Laboratories (azathioprine) |
| |
Novartis (ciclosporin, mycophenolic acid) |
| |
Otsuka Pharmaceuticals (voclosporin) |
| |
Pfizer (rituximab) |
| |
Roche (rituximab, mycophenolate mofetil) |
| |
Rosemont Pharmaceuticals (mycophenolate mofetil) |
| |
Sandoz (cyclophosphamide, mycophenolic acid, rituximab, tacrolimus) |
| |
Santen (ciclosporin) |
| |
Strides Pharma (azathioprine) |
| |
Teva Pharma (mycophenolate mofetil) |
| |
Tillomed Laboratories (azathioprine, mycophenolate mofetil) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Association of Renal Industries |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Confederation |
| |
NHS England Specialised Rheumatology Clinical Reference Group |
| |
NHS Wales Joint Commissioning Committee |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| Relevant research groups |
Cochrane Kidney and Transplant Group |
| |
Genomics England |
| |
Kidney Research UK |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |